Stock ISPH IBNSINA PHARMA
Add to a list
To use this feature you must be a member
Log inSign up

All News Ibnsina Pharma

Equities

ISPH

EGS512O1C012

End-of-day quote Egyptian Exchange
Other stock markets
 06:00:00 2024-07-15 pm EDT 		5-day change 1st Jan Change
2.98 EGP -0.33% Intraday chart for Ibnsina Pharma +1.36% -5.10%
May. 19 Ibnsina Pharma Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Mar. 03 Ibnsina Pharma Reports Earnings Results for the Full Year Ended December 31, 2023 CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Ibnsina Pharma Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Ibnsina Pharma Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Ibnsina Pharma(CASE:ISPH) added to EGX 30 Index
CI
Ibnsina Pharma Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Ibnsina Pharma Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
Ibnsina Pharma(CASE:ISPH) dropped from EGX 30 Index
CI
Ibnsina Pharma Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Ibnsina Pharma Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Ibnsina Pharma Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
CI
Ibnsina Pharma(CASE:ISPH) dropped from S&P Global BMI Index
CI
Ibnsina Pharma Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
Ibnsina Pharma Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
Ibn Sina Pharma Company (S.A.E) acquired El Shorouk Hospital for EGP 430 million.
CI
Ibnsina Pharma Reports Earnings Results for the Full Year Ended December 31, 2021
CI
Ibnsina Pharma Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
CI
Ibn Sina Pharma Company (S.A.E.) Announces Consolidated Earnings Results for the Six Months Ended June 30, 2021
CI
Ibnsina Pharma Reports Consolidated and Standalone Earnings Results for the First Quarter of 2021
CI
Ibnsina Pharma Announces Board Changes
CI
Ibnsina Pharma Appoints Mohamed Mohsen Mohamed Mahgoub as CEO
CI
Ibnsina Pharma Reports Earnings Results for the Full Year 2020
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ISPH Stock
  4. News Ibnsina Pharma